Javaid, S. F., Hashim, I. J., Hashim, M. J., Stip, E., Samad, M. A., & Ahbabi, A. A. (2023). Epidemiology of anxiety disorders: Global burden and sociodemographic associations. Middle East Current Psychiatry, 30, 44.
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., et al. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet, 398, 1700–1712.
Olatunji, B. O., Cisler, J. M., & Tolin, D. F. (2007). Quality of life in the anxiety disorders: A meta-analytic review. Clinical Psychology Review, 27, 572–581.
Newman, M. G., Castonguay, L. G., Borkovec, T. D., Fisher, A. J., Boswell, J. F., Szkodny, L. E., et al. (2011). A randomized controlled trial of cognitive-behavioral therapy for generalized anxiety disorder with integrated techniques from emotion-focused and interpersonal therapies. Journal of Consulting and Clinical Psychology, 79, 171–181.
Article PubMed PubMed Central Google Scholar
Cassano, G. B., Baldini Rossi, N., & Pini, S. (2002). Psychopharmacology of anxiety disorders. Dialogues Clin Neurosci, 4, 271–285.
Article PubMed PubMed Central Google Scholar
Ansara, E. D. (2020). Management of treatment-resistant generalized anxiety disorder. Ment Health Clin, 10, 326–334.
Article PubMed PubMed Central Google Scholar
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., et al. (2020). Pharmacotherapy of anxiety disorders: Current and emerging treatment options. Frontiers in Psychiatry, 11, 595584.
Article PubMed PubMed Central Google Scholar
Eilertsen, S. E. H., & Eilertsen, T. H. (2023). Why is it so hard to identify (consistent) predictors of treatment outcome in psychotherapy? - clinical and research perspectives. BMC Psychol, 11, 198.
Article PubMed PubMed Central Google Scholar
Kramer, B. S., Wilentz, J., Alexander, D., Burklow, J., Friedman, L. M., Hodes, R. (2006). Getting it right: Being smarter about clinical trials. Plos Medicine. ;3: e144.
Akobeng, A. K. (2005). Understanding randomised controlled trials. Archives of Disease in Childhood, 90, 840–844.
Article CAS PubMed PubMed Central Google Scholar
Clarke, J. (2011). What is a systematic review? Evidence-Based Nursing, 14, 64.
Mughal, A. Y., Devadas, J., Ardman, E., Levis, B., Go, V. F., & Gaynes, B. N. (2020). A systematic review of validated screening tools for anxiety disorders and PTSD in low to middle income countries. Bmc Psychiatry, 20, 338.
Article PubMed PubMed Central Google Scholar
Seligman, W. H., Salt, M., la Torre Rosas, A. D., & Das-Gupta, Z. (2019). Unlocking the potential of value-based health care by defining global standard sets of outcome measures that matter to patients with cardiovascular diseases. Eur Heart J Qual Care Clin Outcomes, 5, 92–95.
Obbarius, A., van Maasakkers, L., Baer, L., Clark, D. M., Crocker, A. G., de Beurs, E., et al. (2017). Standardization of health outcomes assessment for depression and anxiety: Recommendations from the ICHOM Depression and anxiety Working Group. Quality of Life Research, 26, 3211–3225.
Article PubMed PubMed Central Google Scholar
COMET initiative [cited 6 Jul 2023]. Available: https://www.comet-initiative.org/About/History.
Kirkham, J. J., Clarke, M., & Williamson, P. R. (2017). A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: Findings from a review of randomised controlled trials of rheumatoid arthritis. Bmj, 357, j2262.
Article PubMed PubMed Central Google Scholar
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. Journal of Clinical Epidemiology, 134, 103–112.
Magee, T., Jones, G., Magana, K., Fitzgerald, K., Modi, J., & Ward, S. OSF. [cited 13 Jul 2023]. Available: https://osf.io/s8zxw/.
Gopalakrishnan, S., & Ganeshkumar, P. (2013). Systematic reviews and Meta-analysis: Understanding the best evidence in primary Healthcare. J Family Med Prim Care, 2, 9–14.
Article CAS PubMed PubMed Central Google Scholar
Bull, S. A., Hunkeler, E. M., Lee, J. Y., Rowland, C. R., Williamson, T. E., Schwab, J. R., et al. (2002). Discontinuing or switching selective serotonin-reuptake inhibitors. Annals of Pharmacotherapy, 36, 578–584.
Worker illness and injury costs U.s employers $225.8 billion annually. [cited 12 Jul 2023]. Available: https://www.cdcfoundation.org/pr/2015/worker-illness-and-injury-costs-us-employers-225-billion-annually.
O’Neill, R. T., & Temple, R. (2012). The prevention and treatment of missing data in clinical trials: An FDA perspective on the importance of dealing with it. Clinical Pharmacology and Therapeutics, 91, 550–554.
Porter, E., Chambless, D. L., McCarthy, K. S., DeRubeis, R. J., Sharpless, B. A., Barrett, M. S., et al. (2017). Psychometric properties of the Reconstructed Hamilton Depression and anxiety scales. The Journal of Nervous and Mental Disease, 205, 656–664.
Article PubMed PubMed Central Google Scholar
Koerner, N., Antony, M. M., & Dugas, M. J. (2010). Limitations of the Hamilton Anxiety Rating Scale as a primary outcome measure in randomized, controlled trials of treatments for generalized anxiety disorder. The American Journal of Psychiatry. pp. 103–104; author reply 104–5.
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166, 1092–1097.
American Psychiatric Association. (1980). Task Force on nomenclature and statistics. Diagnostic and statistical Manual of Mental disorders. American Psychiatric Association.
Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., et al. (2008). Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical Care, 46, 266–274.
Any anxiety disorder In: National Institute of Mental Health (NIMH) [Internet]. [cited 12 Jul 2023]. Available: https://www.nimh.nih.gov/health/statistics/any-anxiety-disorder.
Hughes, K. L., Clarke, M., & Williamson, P. R. (2021). A systematic review finds Core Outcome Set uptake varies widely across different areas of health. Journal of Clinical Epidemiology, 129, 114–123.
Article PubMed PubMed Central Google Scholar
Boric, K., Boric, M., Dosenovic, S., Jelicic Kadic, A., Batinic, M., Cavar, M., et al. (2018). Authors’ lack of awareness and use of core outcome set on postoperative pain in children is hindering comparative effectiveness research. Journal of Comparative Effectiveness Research, 7, 463–470.
Fletcher, J., Sheehan, K. J., & Smith, T. O. (2020). Barriers to uptake of the hip fracture core outcome set: An international survey of 80 hip fracture trialists. Clinical Trials (London, England), 17, 712–716.
Hughes, K. L., Kirkham, J. J., Clarke, M., & Williamson, P. R. (2019). Assessing the impact of a research funder’s recommendation to consider core outcome sets. PLoS One, 14, e0222418.
Article CAS PubMed PubMed Central Google Scholar
Kirkham, J. J., Boers, M., Tugwell, P., Clarke, M., & Williamson, P. R. (2013). Outcome measures in rheumatoid arthritis randomised trials over the last 50 years. Trials, 14, 324.
Article PubMed PubMed Central Google Scholar
Jabonete, F. G. V., & Roxas, R. E. O. (2022). Barriers to research utilization in nursing: A systematic review (2002–2021). SAGE Open Nursing, 8, 23779608221091073.
Article PubMed PubMed Central Google Scholar
Chapter 4 Searching for and selecting studies. [cited 13 Jul 2023]. Available: https://training.cochrane.org/handbook/current/chapter-04.
留言 (0)